EP3377064
Orvepitant til að meðhöndla langvinnan hósta
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.12.2016EP published:
26.6.2019EP application number:
16819325.8
EP translation filed:
18.9.2019Grant published:
15.10.2019EPO information:
European Patent Register
Max expiry date:
26.12.2036Expiry date:
26.12.2025Next due date:
31.12.2025
Title:
ORVEPITANT FOR THE TREATMENT OF CHRONIC COUGH
Timeline
Today
27.12.2016EP application
26.6.2019EP Publication
18.9.2019Translation submitted
15.10.2019Registration published
26.12.2025Expires
Owner
Name:
NeRRe Therapeutics LimitedAddress:
Stevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX , GB
Inventor
Name:
TROWER, MikeAddress:
Stevenage Hertfordshire SG1 2FX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662276237 PDate:
8.1.2016Country:
US
Number:
201662408921 PDate:
17.10.2016Country:
US
Classification
Categories:
A61K 31/4985, A61P 11/14, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 29.11.2019
Expires: 26.12.2020
Payer: PATICE
Number: 5
Paid: 23.11.2020
Expires: 26.12.2021
Payer: Patice ehf.
Number: 6
Paid: 23.11.2021
Expires: 26.12.2022
Payer: Patice ehf.
Number: 7
Paid: 13.12.2022
Expires: 26.12.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.12.2023
Expires: 26.12.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.11.2024
Expires: 26.12.2025
Payer: Árnason Faktor ehf.